FR2426472A1 - Composition pharmaceutique solide stable a usage oral, contenant de la 11-chloro-8,12b-dihydro-2,8-dimethyl - 12b-phenyl - 4h - (1,3)oxazinol(3,2-d)(1,4) benzodiazephine - 4,7 (6h)-dione - Google Patents

Composition pharmaceutique solide stable a usage oral, contenant de la 11-chloro-8,12b-dihydro-2,8-dimethyl - 12b-phenyl - 4h - (1,3)oxazinol(3,2-d)(1,4) benzodiazephine - 4,7 (6h)-dione

Info

Publication number
FR2426472A1
FR2426472A1 FR7913343A FR7913343A FR2426472A1 FR 2426472 A1 FR2426472 A1 FR 2426472A1 FR 7913343 A FR7913343 A FR 7913343A FR 7913343 A FR7913343 A FR 7913343A FR 2426472 A1 FR2426472 A1 FR 2426472A1
Authority
FR
France
Prior art keywords
oxazinol
benzodiazephine
dione
dihydro
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913343A
Other languages
English (en)
French (fr)
Other versions
FR2426472B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2426472A1 publication Critical patent/FR2426472A1/fr
Application granted granted Critical
Publication of FR2426472B1 publication Critical patent/FR2426472B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7913343A 1978-05-26 1979-05-25 Composition pharmaceutique solide stable a usage oral, contenant de la 11-chloro-8,12b-dihydro-2,8-dimethyl - 12b-phenyl - 4h - (1,3)oxazinol(3,2-d)(1,4) benzodiazephine - 4,7 (6h)-dione Granted FR2426472A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/909,924 US4215117A (en) 1978-05-26 1978-05-26 Stable pharmaceutical formulations

Publications (2)

Publication Number Publication Date
FR2426472A1 true FR2426472A1 (fr) 1979-12-21
FR2426472B1 FR2426472B1 (OSRAM) 1982-12-03

Family

ID=25428052

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913343A Granted FR2426472A1 (fr) 1978-05-26 1979-05-25 Composition pharmaceutique solide stable a usage oral, contenant de la 11-chloro-8,12b-dihydro-2,8-dimethyl - 12b-phenyl - 4h - (1,3)oxazinol(3,2-d)(1,4) benzodiazephine - 4,7 (6h)-dione

Country Status (9)

Country Link
US (1) US4215117A (OSRAM)
JP (1) JPS54154516A (OSRAM)
AU (1) AU523773B2 (OSRAM)
CH (1) CH640416A5 (OSRAM)
DE (1) DE2917979A1 (OSRAM)
FR (1) FR2426472A1 (OSRAM)
GB (1) GB2021413B (OSRAM)
IT (1) IT1117180B (OSRAM)
ZA (1) ZA792103B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531866B1 (fr) * 1982-08-20 1985-10-18 Narcisse Guy Comprimes a delitement rapide comprenant des composes du type benzodiazepines
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
JP6075043B2 (ja) * 2012-12-05 2017-02-08 大正製薬株式会社 固形製剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780179A (en) * 1971-08-09 1973-12-18 Upjohn Co Animal feed for obtaining increased production in animals
DE2719690A1 (de) * 1976-05-21 1977-12-08 Yamanouchi Pharma Co Ltd Stabilisierte prostaglandinzubereitung und verfahren zur herstellung derselben

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3573282A (en) * 1969-03-27 1971-03-30 Upjohn Co 4h-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-diones

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780179A (en) * 1971-08-09 1973-12-18 Upjohn Co Animal feed for obtaining increased production in animals
DE2719690A1 (de) * 1976-05-21 1977-12-08 Yamanouchi Pharma Co Ltd Stabilisierte prostaglandinzubereitung und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
IT7949113A0 (it) 1979-05-21
FR2426472B1 (OSRAM) 1982-12-03
AU523773B2 (en) 1982-08-12
US4215117A (en) 1980-07-29
GB2021413B (en) 1983-03-16
ZA792103B (en) 1980-05-28
AU4677179A (en) 1979-11-29
JPS54154516A (en) 1979-12-05
IT1117180B (it) 1986-02-17
GB2021413A (en) 1979-12-05
CH640416A5 (de) 1984-01-13
DE2917979A1 (de) 1979-11-29
JPS6138170B2 (OSRAM) 1986-08-28

Similar Documents

Publication Publication Date Title
US5980880A (en) Aromatic compound containing essential oil and method of producing same
Richter Taste and solubility of toxic compounds in poisoning of rats and man.
RU2135154C1 (ru) Крем для массажа "здоровье"
Larsen Diet and atherosclerosis: A field study
RU2169478C1 (ru) Пищевой функциональный продукт на основе растительных масел
JP4131443B2 (ja) 抗骨粗鬆症組成物
KR900007005B1 (ko) 프로폴리스를 이용한 봉밀향의 제조방법
RU94011006A (ru) Натуральная воскопрополисная кремовая эмульсия
JP5306159B2 (ja) 香料組成物における精神高揚効果の付与方法
JPH0348625A (ja) フィチン酸の安定化組成物及びこれを有効成分とする体臭、尿臭除去剤
JP2638088B2 (ja) 入浴剤
SU1648473A1 (ru) Состав дл лечени зубов
Bartleman et al. Chronic lead poisoning due to grease paint
JP3619978B2 (ja) 粉末状化粧料
FR2575922A1 (fr) Composition de deodorants corporels
KR940008599A (ko) Dha를 함유한 참치안구유 및 어유분말을 첨가하여되는 어육연제품의 제법
RU2127579C1 (ru) Средство для ухода за кожей головы
US20170266105A1 (en) Topical deodorant made with 100% vegan ingredients
RU2010563C1 (ru) Состав для ухода за кожей детей "карапуз"
JP3557579B2 (ja) ソフトカプセル剤
JPS6357515A (ja) 浴剤組成物
JPS6098964A (ja) 美容健康食品
SU1335287A1 (ru) Косметический вазелин
JPS617382A (ja) 抗酸化組成物
RU2014821C1 (ru) Крем для рук

Legal Events

Date Code Title Description
CD Change of name or company name